PT Glori Investama Berjangka
PrimaryBroker profile
Glori Investama Berjangka Review: Is It Legit and Regulated?
PT Glori Investama Berjangka
FindMyFX score
high risk4.3/10
Contact & regulation
- Official website
- gifx.co.id
- Address
- AXA Tower, 28th Floor, Unit OT/28/05, Kuningan City, Jl. Prof. Dr. Satrio Kav. 18, South Jakarta, Indonesia
- Contact
- AXA Tower, 28th Floor, Unit OT/28/05, Kuningan City, Jl. Prof. Dr. Satrio Kav. 18, South Jakarta, Indonesia
- Primary license
- BAPPEBTI · Unverified
Missing values mean the information has not been verified or published yet—not that the broker does not provide it.
Quick verdict
Is Glori Investama Berjangka legit and regulated?
FindMyFX has license records for Glori Investama Berjangka, but none is currently presented as fully verified. Check each entity, jurisdiction, source, and verification date before depositing.
This is a source-limited research summary, not a safety guarantee or investment recommendation.
Broker-provided company information
PT Glori Investama Berjangka is an Indonesian futures broker operating the GIFx website. Bappebti's broker record identifies the firm, while its official site presents foreign exchange, metals, energy, and leveraged CFD products.
Professional broker overview
FindMyFX editorial summary
Glori Investama Berjangka appears in Bappebti's futures-broker directory and operates the GIFx domain. The broker's site presents foreign exchange, metals, energy, and CFD products and states negative-balance protection and supervised segregated client funds. Exact account-level leverage, spreads, platform name, and minimum deposit were not established in the reviewed pages.
Prepared from reviewed sources for informational purposes. This is not investment advice.
Editorial note: Product-protection statements come from the broker's own site and require staff verification against account agreements and current Bappebti rules.
- Operational status
- active
- Broker type
- unknown
- Execution model
- Not verified
- Support hours
- Not verified
Documented advantages
- Bappebti provides a broker-directory record for the legal entity.
- The official site states negative-balance protection and segregated, supervised client funds.
Documented limitations
- Reviewed pages did not establish current leverage, minimum funding, typical spread, or a clearly named platform.
- The official site excludes clients from the United States, Iran, and North Korea.
Published profile coverage
7 of 8 core information groups currently contain published data. This measures data availability, not broker quality or safety.
Company structure
Legal entities
Registered companies associated with this broker profile.
Markets and instruments
CFDs
unverified
Energy
unverified
Foreign exchange
unverified
Metals
unverified
Additional broker contacts
Official email in regulator record
Main telephone
+62 21 3000 7111
Research sources
Licenses and regulators
BAPPEBTI
0001/BAPPEBTI/SI/07/2024
Last verified: Not shown
Jurisdiction-specific offerings
ID · retail
unverifiedEntity not linked · Leverage not shown
Compensation scheme not shown
Score components
Regulation and licenses
7.5/10 · 35%A Bappebti broker-directory record identifies the firm; the licence number was associated with the current broker listing.
Security and track record
2.5/10 · 20%Current official and regulator pages support active operations, but a complete enforcement-history review was not established.
Trading conditions
2.5/10 · 15%Product categories and protection claims are published, while account-level pricing and leverage remain unavailable.
Company transparency
5.0/10 · 10%The regulator and broker pages provide identity, address, telephone, email, website, and restrictions.
Service quality
2.5/10 · 10%Official contact and complaint channels are provided without verified service-quality evidence.
Verified user reviews
0.0/10 · 10%No inspectable source with verified user-review data was identified.
Profile update history
Broker profile was published.
2026-07-20
Related regulated broker profiles
These profiles share at least one recorded regulator. This is not a recommendation or equivalence claim.